Abstract
To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC). In this multicenter Phase I study, 5 patients with unresectable NSCLC received 250 mg gefitinib daily starting 1 week before RT at a dose of 63 Gy (Step 1). After a first safety analysis, 9 patients were treated daily with 250 mg gefitinib plus CRT in the form of RT and weekly CDDP 35 mg/m(2) (Step 2). Gefitinib was maintained for up to 2 years until disease progression or toxicity. Fourteen patients were assessed in the two steps. In Step 1 (five patients were administered only gefitinib and RT), no lung toxicities were seen, and there was no dose-limiting toxicity (DLT). Adverse events were skin and subcutaneous tissue reactions, limited to Grade 1-2. In Step 2, two of nine patients (22.2%) had DLT. One patient suffered from dyspnea and dehydration associated with neutropenic pneumonia, and another showed elevated liver enzymes. In both steps combined, 5 of 14 patients (35.7%) experienced one or more treatment interruptions. Gefitinib (250 mg daily) in combination with RT and CDDP in patients with Stage III NSCLC i...Continue Reading
References
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstPatricia Mucci LoRusso
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaJ Albanell
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Judith S Ochs
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pablo MatarJosé Baselga
Mar 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José Baselga, Carlos L Arteaga
Nov 1, 2005·Lancet·Nick ThatcherKevin Carroll
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Jun 6, 2006·The Lancet Oncology·Fiona BlackhallNick Thatcher
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul A BunnFred R Hirsch
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Everett E VokesUNKNOWN Cancer and Leukemia Group B
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alex ChangNick Thatcher
Apr 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen KellyDavid R Gandara
Jul 3, 2008·Anti-cancer Drugs·Francesco CaponigroStefano Pepe
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Nov 26, 2008·Lancet·Edward S KimJean-Yves Douillard
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corey J Langer
Mar 11, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael J DonovanDinah V Parums
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald B NataleMalcolm Ranson
May 5, 2009·Lancet·Robert PirkerUNKNOWN FLEX Study Team
May 13, 2009·Cancer Science·Hong-Qing ZhuangChang-Li Wang
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Dec 17, 2009·International Journal of Radiation Oncology, Biology, Physics·Greetta JoensuuAkseli Hemminki
Citations
Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S NihoM Fukuoka
May 28, 2013·The Cancer Journal·Josephine FelicianoMinesh Mehta
Nov 21, 2013·Biomarker Research·Alexander ChiWilliam Tse
Apr 26, 2012·The Oncologist·Thomas E Stinchcombe, Jeffrey A Bogart
May 21, 2013·Clinical Lung Cancer·Siddhartha DevarakondaRamaswamy Govindan
Jan 19, 2016·Drug Discovery Today·Andrew F SmithI Michael Wormstone
Dec 27, 2011·Cancer Treatment Reviews·Pek Keng KohDirk De Ruysscher
Aug 12, 2015·Future Oncology·Ilaria MoschiniMarcello Tiseo
Mar 23, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Malte KriegsEkkehard Dikomey
May 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Ritsuko KomakiWaun Ki Hong
Feb 25, 2011·International Journal of Radiation Oncology, Biology, Physics·Jing WangWei-Zhang Wu
Jul 9, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anne Hansen Ree, Donal Hollywood
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph K Salama, Everett E Vokes
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David Raben, Paul A Bunn
Oct 21, 2016·Oncotarget·Antonin LevyCécile Le Péchoux
Jul 12, 2017·Oncology Letters·Mikiko IshiharaNoriyuki Masuda
Nov 22, 2020·International Journal of Radiation Oncology, Biology, Physics·Ligang XingJinming Yu
Mar 23, 2021·Clinical and Translational Radiation Oncology·K HaslettC Faivre-Finn
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S NihoM Fukuoka
Aug 3, 2021·Future Oncology·Xabier Mielgo-RubioFelipe Couñago